Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
As the war grinds on, sophisticated Russian defenses have pushed Ukraine to develop a frightening new weapon: semiautonomous ...
Regardless of the symptoms you experience, the result will be the same: A grinding halt to your forward progress, or worse, ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
Carlie Irsay-Gordon is younger than her peers, with her own distinctive vision of how an NFL owner can lead. It is about to ...
New York Magazine on MSN
Trump Says ‘We’re Going to Run’ Venezuela and ‘Take’ Its Oil: Now What?
Trump sets his military operation in Venezuela to the soundtrack of "Fortunate Son," a song about how the people who start ...
Luddites" is pushing back against screen addiction and questioning whether more technology really means progress.
Seacoast-area letter writers address uninformed complaints about development, GOP's approach to health care, state and ...
As the New Year 2026 approaches, residents of Islamabad and nearby areas are gearing up for a night of concerts, food ...
The order from the U.S. Court of Appeals for the Ninth Circuit is a win for Mr. Newsom, a Democrat, who has vigorously ...
Designers are utilizing an array of programmable or configurable ICs to keep pace with rapidly changing technology and AI.
Dr. Gil Mor discusses sex-specific placental responses and long-term immune alterations from prenatal virus exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results